学術論文　2015

  1. Yasui H, Nakamura Y, Hasegawa H, Fujisawa T, Enomoto N, Inui N, Fukuoka J, et al. A case of spontaneous regression of pulmonary mucosa-associated lymphoid tissue (MALT) type lymphoma with Sjogren’s syndrome treated with methotrexate for rheumatoid arthritis. Respir Med Case Rep 2015;15:4-6.
  2. Yamashita A, Fujimoto Y, Tamaki M, Setiawan A, Tanaka T, Okuyama-Dobashi K, Kasai H, et al. Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay. Mar Drugs 2015;13:6759-6773.
  3. Tatsumi A, Maekawa S, Sato M, Komatsu N, Miura M, Amemiya F, Nakayama Y, et al. Liver stiffness measurement for risk assessment of hepatocellular carcinoma. Hepatol Res 2015;45:523-532.
  4. Shindo K, Maekawa S, Komatsu N, Tatsumi A, Miura M, Sato M, Suzuki Y, et al. Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma. Mediators Inflamm 2015;2015:687484.
  5. Sato M, Maekawa S, Komatsu N, Tatsumi A, Miura M, Muraoka M, Suzuki Y, et al. Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus. J Virol 2015;89:6105-6116.
  6. Sakamoto M, Enomoto N. [Host factors and viral factors in hepatitis C treatment]. Nihon Rinsho 2015;73:208-212.
  7. Sakamoto M, Enomoto N. [Hepatitis C treatment in consideration of the carcinogenic risk and drug-resistant mutations]. Nihon Rinsho 2015;73 Suppl 9:165-170.
  8. Okuyama-Dobashi K, Kasai H, Tanaka T, Yamashita A, Yasumoto J, Chen W, Okamoto T, et al. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. Sci Rep 2015;5:17047.
  9. Ohtaka M, Kobayashi S, Yoshida T, Yamaguchi T, Uetake T, Sato T, Hayashi A, et al. Use of Sato’s curved laryngoscope and an insulated-tip knife for endoscopic incisional therapy of esophageal web. Dig Endosc 2015;27:522-526.
  10. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Enomoto N. Association of splenic MR elastographic findings with gastroesophageal varices in patients with chronic liver disease. J Magn Reson Imaging 2015;41:117-124.
  11. Maekawa S, Enomoto N. [Heterogeneity of HBV genome and its impact on disease progression–Next-generation sequencing analysis focusing on preS region and HBsAg titer]. Nihon Rinsho 2015;73 Suppl 9:402-408.
  12. Kuno T, Kojima Y, Mochizuki H, Fukasawa Y, Kawakami S, Iwamoto F, Hirose S, et al. Factors Predicting Subsequent Hospitalization in Patients with Ulcerative Colitis: Total Colonoscopic Findings are the Strongest Predictor. Hepatogastroenterology 2015;62:821-824.
  13. Kasai H, Kawakami K, Yokoe H, Yoshimura K, Matsuda M, Yasumoto J, Maekawa S, et al. Involvement of FKBP6 in hepatitis C virus replication. Sci Rep 2015;5:16699.
  14. Itakura J, Kurosaki M, Takada H, Nakakuki N, Matsuda S, Gondou K, Asano Y, et al. Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy. Hepatol Res 2015;45:E115-121.
  15. Itakura J, Kurosaki M, Higuchi M, Takada H, Nakakuki N, Itakura Y, Tamaki N, et al. Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy. PLoS One 2015;10:e0138060.
  16. Iio E, Matsuura K, Nishida N, Maekawa S, Enomoto N, Nakagawa M, Sakamoto N, et al. Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C. Hum Genet 2015;134:279-289.
  17. Ichikawa S, Motosugi U, Nakazawa T, Morisaka H, Sano K, Ichikawa T, Enomoto N, et al. Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. J Magn Reson Imaging 2015;41:1203-1208.
  18. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Tatsumi A, Enomoto N, et al. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn Reson Imaging 2015;33:26-30.
  19. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, et al. MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging 2015;42:204-210.
  20. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, et al. Validity and Reliability of Magnetic Resonance Elastography for Staging Hepatic Fibrosis in Patients with Chronic Hepatitis B. Magn Reson Med Sci 2015;14:211-221.
  21. Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, Enomoto N, Matsuda M, et al. Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images? Liver Cancer 2015;4:154-162.
  22. Asakawa Y, Ohtaka M, Maekawa S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, et al. Stratifying the risk of lymph node metastasis in undifferentiated-type early gastric cancer. World J Gastroenterol 2015;21:2683-2692.